[1] Sano T,Sasako M,Yamamoto S, et al.Gastric cancer surgery:morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy-Japan Clinical Oncology Group study 9501[J]. J Clin Oncol,2004,22:2767-2773.
[2] Kuniaki C,Shimada H,Yamaoka H,Wakasugi J,Takahashi M,Akiyama H, etal.Significance of para-aortic lymph node dissection for advancedgastric cancer[J].Hepatogastroenterology, 1999,46:2635-2642.
[3] 吴 晖,张信华,徐建波,等.进展期胃癌腹主动脉旁淋巴结转移的相关因素及其对预后的影响吴晖,张信华,徐建波,等.进展期胃癌腹主动脉旁淋巴结转移的相关因素及其对预后的影响.消化肿瘤杂志(电子版),2012,6(4):82-87.
[4] 郑朝旭,郑荣寿,张思维,等.中国2010年胃癌发病与死亡分析[J].中国肿瘤,2014,10(23):795-800.
[5] Maeta M,Yamashiro H,Saito H, et al.A prospective pilot study of extened (D3) and superextended para-aortic lymphadenectomy (D4) in patients with T3 or T4 gastric cancer managed by total gastrectomy[J].Surgery,1999,125(3):325-331.
[6] Koizumi W, Akiya T, Sato A, et al. Phase Ⅱ study of S-1 as first-line treatment for elderly patients over 75 years of age with advanced gastric cancer: the Tokyo Cooperative Oncology Group study [J]. Cancer chemother pharmacol,2010,65(6):1093-1099.
[7] Boku N.Chemotherapy for metastatic disease:review from JCOG trial[J].International Journal of Clinical Oncology,2008,13(3):196.
[8] 王 亮,何裕隆,蔡世荣,等.关于进展期胃癌根治术淋巴结清扫范围的荟萃分析[J].消化肿瘤杂志(电子版),2009,9(1):33-40.